Snowball logo
logo
GELS

Gelteq Limited Ordinary Shares

GELS • NASDAQ
$0.4354-$0.0119  (2.66%)
Estimate
EPS
-0.44
Beta
1.077
About the company
Ticker
GELS
ISIN
AU0000218109
Country
Australia
Sector (GICS)
Healthcare
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Frequently asked questions

What sector does Gelteq Limited Ordinary Shares (GELS) operate in?

Gelteq Limited Ordinary Shares belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Gelteq Limited Ordinary Shares (GELS) current stock price?

As of the latest data, Gelteq Limited Ordinary Shares stock price is $0.44, with a previous close of $0.45. Gelteq Limited Ordinary Shares lost -$0.01 in the last trading session, representing a -2.66% loss.

What is Gelteq Limited Ordinary Shares (GELS) current market capitalization?

Gelteq Limited Ordinary Shares market cap is approximately 4.66 million.

What is Gelteq Limited Ordinary Shares (GELS) Earnings Per Share (EPS)?

The trailing EPS is -$0.44.

Does Gelteq Limited Ordinary Shares (GELS) pay dividends?

No. Gelteq Limited Ordinary Shares does not pay a dividend.

What is Gelteq Limited Ordinary Shares (GELS) beta (volatility) score?

Gelteq Limited Ordinary Shares has a beta of 1.077, meaning its volatility is roughly in line with the market.